Susquehanna International Group’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Susquehanna International Group’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,800	Closed	-$310K	–	13487
2024 Q1	$310K	Sell	8,800 -1,600	-15%	-$53.6K	﹤0.01%	9640
2023 Q4	$300K	Sell	10,400 -109,800	-91%	-$2.61M	﹤0.01%	9832
2023 Q3	$2.75M	Buy	120,200 +66,200	+123%	+$3.47M	﹤0.01%	4535
2023 Q2	$3.1M	Sell	54,000 -29,700	-35%	-$1.55M	﹤0.01%	4313
2023 Q1	$3.15M	Buy	+83,700	New	+$3.08M	﹤0.01%	4229
2022 Q2	–	Sell	-10,600	Closed	-$426K	–	14205
2022 Q1	$426K	Buy	+10,600	New	+$444K	﹤0.01%	9388

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return

Susquehanna International Group's MORF Position: Q3 2024 in Review

Susquehanna International Group sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 85,932 shares — an estimated $2.93M sold.

Susquehanna International Group first reported a position in MORF in Q2 2021 and held it in 11 quarters. The position peaked at $2.93M in Q2 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

Susquehanna International Group reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group sold 85,932 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $2.93M.
Susquehanna International Group first reported a position in Morphic Holding, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Susquehanna International Group's Morphic Holding, Inc. Common Stock position peaked at $2.93M in Q2 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.